The results of our joint research with Professor Hiroshi Handa, Tokyo Medical University, have been published in iScience (a new journal from Cell Press). This study reveals a new function of cereblon (CRBN), an intracellular target protein of thalidomide, using zebrafish as a model organism. CRBN regulates the proliferation of neural stem cells. Since CRBN is a drug discovery target, the development of new therapeutic drugs for neurological diseases targeting CRBN is expected. For detail, please also see the press release below.